186 related articles for article (PubMed ID: 20385122)
1. In vivo efficacy of acyl CoA: diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemia.
King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Collins CA; Voorbach MJ; Zhao G; Mittelstadt SW; Cox BF
Eur J Pharmacol; 2010 Jul; 637(1-3):155-61. PubMed ID: 20385122
[TBL] [Abstract][Full Text] [Related]
2. Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamster.
King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Zhao G; Mittelstadt SW; Cox BF
J Pharmacol Exp Ther; 2009 Aug; 330(2):526-31. PubMed ID: 19478132
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of diacylglycerol acyltransferase: a review of 2008 patents.
King AJ; Judd AS; Souers AJ
Expert Opin Ther Pat; 2010 Jan; 20(1):19-29. PubMed ID: 20021283
[TBL] [Abstract][Full Text] [Related]
4. Increased diacylglycerol acyltransferase activity is associated with triglyceride accumulation in tissues of diet-induced insulin-resistant hyperlipidemic hamsters.
Casaschi A; Maiyoh GK; Adeli K; Theriault AG
Metabolism; 2005 Mar; 54(3):403-9. PubMed ID: 15736121
[TBL] [Abstract][Full Text] [Related]
5. Identification and preliminary characterization of a potent, safe, and orally efficacious inhibitor of acyl-CoA:diacylglycerol acyltransferase 1.
Yeh VS; Beno DW; Brodjian S; Brune ME; Cullen SC; Dayton BD; Dhaon MK; Falls HD; Gao J; Grihalde N; Hajduk P; Hansen TM; Judd AS; King AJ; Klix RC; Larson KJ; Lau YY; Marsh KC; Mittelstadt SW; Plata D; Rozema MJ; Segreti JA; Stoner EJ; Voorbach MJ; Wang X; Xin X; Zhao G; Collins CA; Cox BF; Reilly RM; Kym PR; Souers AJ
J Med Chem; 2012 Feb; 55(4):1751-7. PubMed ID: 22263872
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
[TBL] [Abstract][Full Text] [Related]
7. Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes.
Qian Y; Wertheimer SJ; Ahmad M; Cheung AW; Firooznia F; Hamilton MM; Hayden S; Li S; Marcopulos N; McDermott L; Tan J; Yun W; Guo L; Pamidimukkala A; Chen Y; Huang KS; Ramsey GB; Whittard T; Conde-Knape K; Taub R; Rondinone CM; Tilley J; Bolin D
J Med Chem; 2011 Apr; 54(7):2433-46. PubMed ID: 21413799
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure.
Vaziri ND; Kim CH; Dang B; Zhan CD; Liang K
Am J Physiol Renal Physiol; 2004 Jul; 287(1):F90-4. PubMed ID: 15010358
[TBL] [Abstract][Full Text] [Related]
9. Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor.
Zhao G; Souers AJ; Voorbach M; Falls HD; Droz B; Brodjian S; Lau YY; Iyengar RR; Gao J; Judd AS; Wagaw SH; Ravn MM; Engstrom KM; Lynch JK; Mulhern MM; Freeman J; Dayton BD; Wang X; Grihalde N; Fry D; Beno DW; Marsh KC; Su Z; Diaz GJ; Collins CA; Sham H; Reilly RM; Brune ME; Kym PR
J Med Chem; 2008 Feb; 51(3):380-3. PubMed ID: 18183944
[TBL] [Abstract][Full Text] [Related]
10. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat.
Smith SJ; Cases S; Jensen DR; Chen HC; Sande E; Tow B; Sanan DA; Raber J; Eckel RH; Farese RV
Nat Genet; 2000 May; 25(1):87-90. PubMed ID: 10802663
[TBL] [Abstract][Full Text] [Related]
11. Discovery of indolyl acrylamide derivatives as human diacylglycerol acyltransferase-2 selective inhibitors.
Lee K; Kim M; Lee B; Goo J; Kim J; Naik R; Seo JH; Kim MO; Byun Y; Song GY; Lee HS; Choi Y
Org Biomol Chem; 2013 Feb; 11(5):849-58. PubMed ID: 23242135
[TBL] [Abstract][Full Text] [Related]
12. Diacylglycerol acyltransferase-inhibitory compounds from Erythrina senegalensis.
Oh WK; Lee C; Seo JH; Chung MY; Cui L; Fomum ZT; Kang JS; Lee HS
Arch Pharm Res; 2009 Jan; 32(1):43-7. PubMed ID: 19183875
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans.
Maciejewski BS; LaPerle JL; Chen D; Ghosh A; Zavadoski WJ; McDonald TS; Manion TB; Mather D; Patterson TA; Hanna M; Watkins S; Gibbs EM; Calle RA; Steppan CM
Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G958-69. PubMed ID: 23558010
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
[TBL] [Abstract][Full Text] [Related]
15. A simple homogeneous scintillation proximity assay for acyl-coenzyme A:diacylglycerol acyltransferase.
Seethala R; Peterson T; Dong J; Chu CH; Chen L; Golla R; Ma Z; Panemangalore R; Lawrence RM; Cheng D
Anal Biochem; 2008 Dec; 383(2):144-50. PubMed ID: 18834848
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a potent, selective, and orally efficacious pyrimidinooxazinyl bicyclooctaneacetic acid diacylglycerol acyltransferase-1 inhibitor.
Birch AM; Birtles S; Buckett LK; Kemmitt PD; Smith GJ; Smith TJ; Turnbull AV; Wang SJ
J Med Chem; 2009 Mar; 52(6):1558-68. PubMed ID: 19256504
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of thiazole containing biaryl analogs as diacylglycerol acyltransferase 1 (DGAT1) inhibitors.
Kadam KS; Jadhav RD; Kandre S; Guha T; Reddy MM; Brahma MK; Deshmukh NJ; Dixit A; Doshi L; Srinivasan S; Devle J; Damre A; Nemmani KV; Gupte A; Sharma R
Eur J Med Chem; 2013 Jul; 65():337-47. PubMed ID: 23735282
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice.
Chen HC; Farese RV
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):482-6. PubMed ID: 15569818
[TBL] [Abstract][Full Text] [Related]
19. Novel acyl coenzyme A (CoA): diacylglycerol acyltransferase-1 inhibitors: synthesis and biological activities of diacylethylenediamine derivatives.
Nakada Y; Aicher TD; Le Huerou Y; Turner T; Pratt SA; Gonzales SS; Boyd SA; Miki H; Yamamoto T; Yamaguchi H; Kato K; Kitamura S
Bioorg Med Chem; 2010 Apr; 18(7):2785-95. PubMed ID: 20207151
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors.
Lee K; Goo JI; Jung HY; Kim M; Boovanahalli SK; Park HR; Kim MO; Kim DH; Lee HS; Choi Y
Bioorg Med Chem Lett; 2012 Dec; 22(24):7456-60. PubMed ID: 23141914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
